DSE : ORIONINFU
Orion Infusion Limited — Financial statements
Biological Products, Except Diagnostic Substances · Bangladesh
Last price 228.7 BDT (At close: Oct 28, 2026) · Market cap 4.66B
Latest research: Orion Infusion financial analysis: ten flat years, 20% FY2025 sales fall and a 131x P/E (Oct 2026) · Orion Infusion: FY2025 sales fell 20% to BDT 665m and 9M FY2026 sales fell a further 3.5%, while the shares trade at 131x trailing earnings
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Technical report: trend, RSI, support and resistance, charts
Financial statements
Orion Infusion Limited (ORIONINFU) reported revenue of 647.55M BDT (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year July - June; amounts in BDT.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 647.55M | 664.92M | 827.42M | 810.15M | 829.57M | 727.40M |
| Cost of Revenue | 380.16M | 386.00M | 493.27M | 483.93M | 490.03M | 430.36M |
| Gross Profit | 267.40M | 278.92M | 334.15M | 326.23M | 339.54M | 297.04M |
| Selling, General & Admin | 193.62M | 194.84M | 250.01M | 247.80M | 246.98M | 215.97M |
| Operating Expenses | 193.62M | 194.84M | 250.01M | 247.80M | 246.98M | 215.97M |
| Operating Income | 73.77M | 84.09M | 84.14M | 78.43M | 92.56M | 81.07M |
| Interest Expense | -34.27M | -39.76M | -32.72M | -27.19M | -26.64M | -26.30M |
| Interest & Investment Income | 262.84K | 221.64K | 434.08K | 208.15K | 352.01K | 147.71K |
| Other Non Operating Income (Expenses) | 4.25M | -636.53K | -701.92K | -1.11M | -1.77M | -849.08K |
| EBT Excluding Unusual Items | 44.01M | 43.91M | 51.15M | 50.34M | 64.50M | 54.07M |
| Gain (Loss) on Sale of Investments | 526.03K | 148.69K | -44.49K | -35.45K | 815.02K | -1.77M |
| Pretax Income | 44.53M | 44.06M | 51.11M | 50.30M | 65.32M | 52.30M |
| Income Tax Expense | 9.02M | 9.03M | 8.78M | 8.40M | 22.50M | 24.42M |
| Net Income | 35.51M | 35.02M | 42.33M | 41.90M | 42.82M | 27.88M |
| Net Income to Common | 35.51M | 35.02M | 42.33M | 41.90M | 42.82M | 27.88M |
| Shares Outstanding (Basic) | 20.36M | 20.36M | 20.36M | 20.36M | 20.36M | 20.36M |
| Shares Outstanding (Diluted) | 20.36M | 20.36M | 20.36M | 20.36M | 20.36M | 20.36M |
| EPS (Basic) | 1.74 | 1.72 | 2.08 | 2.06 | 2.10 | 1.37 |
| EPS (Diluted) | 1.74 | 1.72 | 2.08 | 2.06 | 2.10 | 1.37 |
| Free Cash Flow | 65.98M | 20.66M | 46.04M | -7.25M | 26.01M | 6.42M |
| Free Cash Flow Per Share | 3.24 | 1.01 | 2.26 | -0.36 | 1.28 | 0.32 |
| Dividend Per Share | 2.00 | 2.00 | 1.20 | 1.00 | 2.00 | 1.00 |
| Gross Margin | 41.29% | 41.95% | 40.38% | 40.27% | 40.93% | 40.84% |
| Operating Margin | 11.39% | 12.65% | 10.17% | 9.68% | 11.16% | 11.14% |
| Profit Margin | 5.48% | 5.27% | 5.12% | 5.17% | 5.16% | 3.83% |
| Free Cash Flow Margin | 10.19% | 3.11% | 5.56% | -0.90% | 3.14% | 0.88% |
| EBITDA | 78.82M | 96.49M | 99.51M | 93.82M | 103.03M | 91.16M |
| EBITDA Margin | 12.17% | 14.51% | 12.03% | 11.58% | 12.42% | 12.53% |
| D&A For EBITDA | 5.05M | 12.40M | 15.37M | 15.39M | 10.47M | 10.09M |
| EBIT | 73.77M | 84.09M | 84.14M | 78.43M | 92.56M | 81.07M |
| EBIT Margin | 11.39% | 12.65% | 10.17% | 9.68% | 11.16% | 11.14% |
| Effective Tax Rate | 20.26% | 20.50% | 17.17% | 16.70% | 34.45% | 46.69% |
| Advertising Expenses | 2.50M | 2.69M | 2.67M | 3.11M | 2.74M |
Balance sheet
Fiscal year July - June; amounts in BDT.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 13.52M | 12.41M | 22.34M | 44.99M | 32.57M | 10.35M |
| Cash & Short-Term Investments | 13.52M | 12.41M | 22.34M | 44.99M | 32.57M | 10.35M |
| Accounts Receivable | 148.19M | 153.28M | 124.83M | 131.87M | 148.35M | 141.01M |
| Receivables | 148.19M | 153.28M | 124.83M | 131.87M | 148.35M | 141.01M |
| Inventory | 113.71M | 129.03M | 139.51M | 125.19M | 103.43M | 91.28M |
| Other Current Assets | 174.90M | 169.04M | 151.20M | 133.46M | 112.43M | 87.79M |
| Total Current Assets | 450.32M | 463.76M | 437.88M | 435.51M | 396.77M | 330.43M |
| Property, Plant & Equipment | 352.13M | 359.82M | 364.15M | 377.56M | 334.88M | 322.75M |
| Long-Term Investments | 23.36M | 23.65M | 22.72M | 23.63M | 25.43M | 22.63M |
| Other Long-Term Assets | 1.00 | |||||
| Total Assets | 825.81M | 847.23M | 824.74M | 836.70M | 757.09M | 675.80M |
| Accounts Payable | 50.46M | 55.55M | 53.20M | 45.84M | 40.66M | 40.34M |
| Accrued Expenses | 21.96M | 26.36M | 29.72M | 28.24M | 21.52M | 16.41M |
| Short-Term Debt | 279.44M | 305.74M | 305.15M | 347.21M | 292.54M | 258.99M |
| Current Portion of Long-Term Debt | 777.97K | 2.41M | 3.45M | |||
| Current Portion of Leases | 5.15M | 6.07M | 6.16M | 9.54M | 9.22M | 8.30M |
| Current Income Taxes Payable | 79.87M | 72.54M | 64.49M | 54.89M | 46.56M | 33.88M |
| Other Current Liabilities | 27.45M | 25.46M | 24.79M | 22.55M | 5.77M | 11.71M |
| Total Current Liabilities | 464.33M | 491.72M | 483.51M | 509.05M | 418.68M | 373.09M |
| Long-Term Debt | 246.79K | 1.25M | ||||
| Long-Term Leases | 11.04M | 9.16M | 7.02M | 14.28M | 24.67M | 21.63M |
| Long-Term Deferred Tax Liabilities | 20.38M | 20.25M | 19.59M | 21.73M | 22.04M | 13.03M |
| Other Long-Term Liabilities | -1.00 | -1.00 | 1.89M | |||
| Total Liabilities | 495.75M | 521.13M | 510.12M | 545.05M | 467.52M | 409.00M |
| Common Stock | 203.60M | 203.60M | 203.60M | 203.60M | 203.60M | 203.60M |
| Retained Earnings | -6.02M | -11.89M | -24.04M | -48.44M | -51.76M | -76.04M |
| Comprehensive Income & Other | 132.49M | 134.39M | 135.07M | 136.49M | 137.73M | 139.24M |
| Shareholders' Equity | 330.07M | 326.10M | 314.62M | 291.65M | 289.57M | 266.80M |
| Total Liabilities & Equity | 825.81M | 847.23M | 824.74M | 836.70M | 757.09M | 675.80M |
| Total Debt | 295.63M | 320.97M | 318.34M | 371.81M | 329.09M | 293.62M |
| Net Cash (Debt) | -275.98M | -302.12M | -290.48M | -320.37M | -288.26M | -277.81M |
| Net Cash Per Share | -13.56 | -14.84 | -14.27 | -15.74 | -14.16 | -13.64 |
| Filing Date Shares Outstanding | 20.36M | 20.36M | 20.36M | 20.36M | 20.36M | 20.36M |
| Total Common Shares Outstanding | 20.36M | 20.36M | 20.36M | 20.36M | 20.36M | 20.36M |
| Working Capital | -14.00M | -27.96M | -45.63M | -73.54M | -21.90M | -42.67M |
| Book Value Per Share | 16.21 | 16.02 | 15.45 | 14.32 | 14.22 | 13.10 |
| Tangible Book Value | 330.07M | 326.10M | 314.62M | 291.65M | 289.57M | 266.80M |
| Tangible Book Value Per Share | 16.21 | 16.02 | 15.45 | 14.32 | 14.22 | 13.10 |
| Land | 129.50M | 129.50M | 129.50M | 129.50M | 129.50M | |
| Buildings | 184.68M | 184.68M | 182.82M | 179.86M | 179.86M | |
| Machinery | 518.15M | 512.36M | 502.81M | 440.06M | 406.14M |
Cash flow statement
Fiscal year July - June; amounts in BDT.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 35.51M | 35.02M | 42.33M | 41.90M | 42.82M | 27.88M |
| Depreciation & Amortization | 16.96M | 19.23M | 23.28M | 24.82M | 20.21M | 20.58M |
| Loss (Gain) From Sale of Investments | -526.03K | -148.69K | 44.49K | 35.45K | -815.02K | 1.77M |
| Other Operating Activities | -3.24M | -10.71M | -14.50M | -21.43M | -432.75K | 6.37M |
| Change in Accounts Receivable | -26.49M | -28.45M | 7.04M | 16.48M | -7.34M | -8.09M |
| Change in Inventory | 44.82M | 10.48M | -14.32M | -21.76M | -12.15M | -14.64M |
| Change in Accounts Payable | -5.77M | 2.34M | 7.37M | 5.18M | 315.09K | 3.10M |
| Change in Other Net Operating Assets | 5.43M | -1.30M | 6.21M | 15.44M | 2.83M | -8.45M |
| Operating Cash Flow | 66.71M | 26.45M | 57.45M | 60.67M | 45.45M | 28.54M |
| Capital Expenditures | -730.51K | -5.79M | -11.41M | -67.92M | -19.44M | -22.12M |
| Sale of Property, Plant & Equipment | 379.30K | |||||
| Investment in Securities | -725.18K | -373.51K | -13.85K | 6.13K | -1.01M | 65.34M |
| Other Investing Activities | 1.00 | 1.00 | -1.00 | |||
| Investing Cash Flow | -1.46M | -6.16M | -11.43M | -67.53M | -20.45M | 43.23M |
| Short-Term Debt Issued | 590.51K | 54.67M | 33.55M | |||
| Total Debt Issued | 590.51K | 590.51K | 54.67M | 33.55M | ||
| Short-Term Debt Repaid | -42.06M | -47.02M | ||||
| Long-Term Debt Repaid | -7.05M | -9.08M | -11.12M | -11.00M | -11.74M | |
| Lease Payments | -7.05M | -7.05M | -9.08M | -11.12M | -11.00M | -11.74M |
| Total Debt Repaid | -30.40M | -7.05M | -51.14M | -11.12M | -11.00M | -58.76M |
| Net Debt Issued (Repaid) | -29.81M | -6.46M | -51.14M | 43.55M | 22.55M | -58.76M |
| Common Dividends Paid | -45.61M | -23.76M | -17.53M | -24.26M | -25.33M | -14.56M |
| Other Financing Activities | 4.00 | 1.00 | ||||
| Financing Cash Flow | -75.42M | -30.22M | -68.67M | 19.29M | -2.78M | -73.32M |
| Miscellaneous Cash Flow Adjustments | -3.00 | -2.00 | 1.00 | |||
| Net Cash Flow | -10.17M | -9.93M | -22.65M | 12.42M | 22.22M | -1.56M |
| Free Cash Flow | 65.98M | 20.66M | 46.04M | -7.25M | 26.01M | 6.42M |
| Free Cash Flow Margin | 10.19% | 3.11% | 5.56% | -0.90% | 3.14% | 0.88% |
| Free Cash Flow Per Share | 3.24 | 1.01 | 2.26 | -0.36 | 1.28 | 0.32 |
| Levered Free Cash Flow | 32.86M | 13.04M | 39.67M | -373.99K | 10.00M | 72.89M |
| Unlevered Free Cash Flow | 54.28M | 37.89M | 60.12M | 16.62M | 26.65M | 89.33M |
| Free Cash Flow After Leases | 58.93M | 13.61M | 36.96M | -18.37M | 15.01M | -5.32M |
| Cash Interest Paid | 34.02M | 39.76M | 32.72M | 27.19M | 26.64M | 26.30M |
| Cash Income Tax Paid | 12.78M | 19.90M | 23.23M | 29.43M | 23.75M | 16.28M |
| Change in Working Capital | 18.00M | -16.93M | 6.30M | 15.34M | -16.34M | -28.07M |
Ratios
Fiscal year July - June; amounts in BDT.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 4.63B | 6.39B | 9.78B | 6.85B | 1.78B | 1.39B |
| Enterprise Value | 4.90B | 6.67B | 10.06B | 7.16B | 3.59B | 1.67B |
| Last Close Price | 227.20 | 312.09 | 476.14 | 332.35 | 85.90 | 66.58 |
| PE Ratio | 130.26 | 182.36 | 231.09 | 163.50 | 41.51 | 50.02 |
| PS Ratio | 7.14 | 9.61 | 11.82 | 8.46 | 2.14 | 1.92 |
| PB Ratio | 14.01 | 19.59 | 31.09 | 23.49 | 6.14 | 5.23 |
| P/TBV Ratio | 14.01 | 19.59 | 31.09 | 23.49 | 6.14 | 5.23 |
| P/FCF Ratio | 70.11 | 309.08 | 212.49 | 68.34 | 217.25 | |
| P/OCF Ratio | 69.34 | 241.43 | 170.28 | 112.93 | 39.11 | 48.87 |
| EV/Sales Ratio | 7.57 | 10.04 | 12.15 | 8.83 | 4.32 | 2.29 |
| EV/EBITDA Ratio | 57.25 | 69.16 | 101.06 | 76.27 | 34.80 | 18.28 |
| EV/EBIT Ratio | 66.44 | 79.36 | 119.51 | 91.23 | 38.73 | 20.56 |
| EV/FCF Ratio | 74.29 | 322.94 | 218.42 | 137.84 | 259.65 | |
| Debt / Equity Ratio | 0.90 | 0.98 | 1.01 | 1.27 | 1.14 | 1.10 |
| Debt / EBITDA Ratio | 3.45 | 3.11 | 2.96 | 3.60 | 2.92 | 2.89 |
| Debt / FCF Ratio | 4.48 | 15.53 | 6.92 | 12.65 | 45.74 | |
| Net Debt / Equity Ratio | 0.84 | 0.93 | 0.92 | 1.10 | 0.99 | 1.04 |
| Net Debt / EBITDA Ratio | 3.50 | 3.13 | 2.92 | 3.42 | 2.80 | 3.05 |
| Net Debt / FCF Ratio | 4.18 | 14.62 | 6.31 | -44.16 | 11.08 | 43.28 |
| Asset Turnover | 0.77 | 0.80 | 1.00 | 1.02 | 1.16 | 1.06 |
| Inventory Turnover | 2.79 | 2.88 | 3.73 | 4.23 | 5.03 | 5.13 |
| Quick Ratio | 0.35 | 0.34 | 0.30 | 0.35 | 0.43 | 0.41 |
| Current Ratio | 0.97 | 0.94 | 0.91 | 0.86 | 0.95 | 0.89 |
| Return on Equity (ROE) | 10.93% | 10.93% | 13.96% | 14.42% | 15.39% | 10.63% |
| Return on Assets (ROA) | 5.47% | 6.29% | 6.33% | 6.15% | 8.08% | 7.37% |
| Return on Invested Capital (ROIC) | 9.73% | 10.74% | 11.34% | 10.85% | 10.68% | 7.61% |
| Return on Capital Employed (ROCE) | 20.40% | 23.70% | 24.70% | 23.90% | 27.40% | 26.80% |
| Earnings Yield | 0.77% | 0.55% | 0.43% | 0.61% | 2.41% | 2.00% |
| FCF Yield | 1.43% | 0.32% | 0.47% | -0.11% | 1.46% | 0.46% |
| Dividend Yield | 0.88% | 0.64% | 0.25% | 0.30% | 2.29% | 1.46% |
| Payout Ratio | 128.43% | 67.84% | 41.41% | 57.90% | 59.14% | 52.21% |
| Total Shareholder Return | 0.88% | 0.64% | 0.25% | 0.30% | 2.29% | 1.46% |